Literature DB >> 9661669

Structure and expression of the human MTG8/ETO gene.

J K Wolford1, M Prochazka.   

Abstract

Translocations involving the putative proto-oncogene MTG8/ETO on 8q22 are frequently found in acute myeloid leukemia. To date, little is known of the genomic organization of this gene. Here, we report that the MTG8 gene consists of 13 exons distributed over 87 kb of genomic DNA. Two polymorphic microsatellite repeats are described, including one in intron 3 (three alleles; heterozygosity 0.34) and another in the 3'UTR (15 alleles; heterozygosity 0.89). Expression of MTG8 was detected in a variety of normal human tissues with the highest mRNA levels occurring in brain and heart. Previously, two mRNA forms produced by the alternative usage of the first exon have been reported. We now describe a novel, abundantly expressed, alternatively spliced transcript resulting from the inclusion of a 155-bp exon (designated 9a) that changes the reading frame and introduces a premature stop codon. Identical alternatively spliced mRNA variants were found to be produced by the highly conserved homologous gene (Cbfa2t1) in the mouse, suggesting an evolutionary significance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9661669     DOI: 10.1016/s0378-1119(98)00141-3

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  22 in total

1.  Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development.

Authors:  Ming Yan; Sebastien A Burel; Luke F Peterson; Eiki Kanbe; Hiromi Iwasaki; Anita Boyapati; Robert Hines; Koichi Akashi; Dong-Er Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-29       Impact factor: 11.205

Review 2.  Fusion-protein truncation provides new insights into leukemogenesis.

Authors:  Jay L Hess; Bruce A Hug
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-30       Impact factor: 11.205

3.  New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins.

Authors:  Jian Li; Chun Guo; Nickolas Steinauer; Jinsong Zhang
Journal:  Front Biol (Beijing)       Date:  2016-09-03

Review 4.  AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches.

Authors:  Megan A Hatlen; Lan Wang; Stephen D Nimer
Journal:  Front Med       Date:  2012-08-09       Impact factor: 4.592

Review 5.  Role of RUNX1 in hematological malignancies.

Authors:  Raman Sood; Yasuhiko Kamikubo; Paul Liu
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

6.  Gene targeting reveals a crucial role for MTG8 in the gut.

Authors:  F Calabi; R Pannell; G Pavloska
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

7.  Characterization of a t(5;8)(q31;q21) translocation in a patient with mental retardation and congenital heart disease: implications for involvement of RUNX1T1 in human brain and heart development.

Authors:  Litu Zhang; Zeynep Tümer; Kjeld Møllgård; Gotthold Barbi; Eva Rossier; Eske Bendsen; Rikke Steensbjerre Møller; Reinhard Ullmann; Jian He; Nickolas Papadopoulos; Niels Tommerup; Lars Allan Larsen
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

8.  The leukemia associated ETO nuclear repressor gene is regulated by the GATA-1 transcription factor in erythroid/megakaryocytic cells.

Authors:  Ram Ajore; Rakesh Singh Dhanda; Urban Gullberg; Inge Olsson
Journal:  BMC Mol Biol       Date:  2010-05-20       Impact factor: 2.946

9.  The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO.

Authors:  Luke F Peterson; Ming Yan; Dong-Er Zhang
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

10.  Regional expression of MTG genes in the developing mouse central nervous system.

Authors:  Amin Alishahi; Naoko Koyano-Nakagawa; Yasushi Nakagawa
Journal:  Dev Dyn       Date:  2009-08       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.